$2.8 billion variety This Anhui pharmaceutical company will take it.

A few days ago, the official website of the State Drug Administration shows that Anhui Baker Bio to imitate the 4 categories of reported Enqutha Binte Nofowe tablets into the administrative approval stage, sprinting the variety of domestic 2nd.
2019 global sales of more than $2.8 billion as a drug used to treat AIDS.
entourtabinofovir tablets contain two active ingredients: entourtabin and fumarate nofovir difficide, both highly effective antiretroviral drugs.
entourage nofovir tablets as a single tablet, with simplified treatment, significant efficacy, high patient compliance, low drug resistance and so on, has been included in the national health insurance Class B drugs.
Truvada, the original manufacturer of Truvada, was first approved by the FDA in August 2004 for the treatment of HIV-1 infection with other antiretroviral drugs, and in 2012 was approved by the FDA for sexually transmitted HIV-1 infection in adults, the world's first HIV prevention drug.
2019, Truvada's global sales exceeded $2.8 billion, according to Gilead Financial Results.
Truvada Global Sales (in millions of U.S. dollars) Source: Milnet Multinational Listed Companies Sales Database The current domestic market Entrutha Binte Nofowe tablet approval enterprises only Gilead and Zhengda Tianqing Pharmaceutical Group, Zhengda Tianqing Pharmaceutical Group in June 2020 to take the first imitation of the species;
Enqutai Bintinofove film pending approval enterprise source: Mi Net one-click retrieval MiNet data show that Hesco and Qilu Pharmaceutical's Enturt Bintinofowe film listing application in the review, Anhui Baker Bio's Enqutai Bintinofowe film registration status has been changed to "in the approval", if successfully approved will become the second domestic.
source: MiNet Database, NMPA.